Light Chain Bioscience
PrivateLast Round
VC Round
May 11, 2016
Total Funding Raised
$196.6M
Company Overview
Light Chain Bioscience operates in Healthcare & Life Sciences and is based in Plan-les-Ouates. Its latest recorded funding round was a VC Round in May 2016.
Light Chain Bioscience is a drug discovery company that develops multi-specific antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Light Chain Bioscience Comparables
Compare Light Chain Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymeworks Inc. | 81% | |
| Xencor, Inc. | 79% | |
| Merus N.V. | 79% |
For institutional investors. Book with your work email.
Light Chain Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 11, 2016 | ||||
| VC Round | Jan 13, 2016 | ||||
| Series B | Feb 18, 2014 | ||||
| Series A | Apr 28, 2000 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Light Chain Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BZ Bank Aktiengesellschaft | Series B |
| Rosetta Capital | Series B |
| Lombard Odier | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 303% MoM, reaching 4.4K.
- Feb 11, 2026
Grew 43% QoQ, from 53 to 76 employees.
For institutional investors. Book with your work email.
Light Chain Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Light Chain Bioscience's valuation, stock price, and market status.
Is Light Chain Bioscience a public or private company?
Light Chain Bioscience is a private company.
What is the current stock price of Light Chain Bioscience?
Light Chain Bioscience is a private company, so its shares have no public market price. Caplight tracks Light Chain Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Light Chain Bioscience worth (valuation)?
Valuation information for Light Chain Bioscience is not publicly available.
Can I buy Light Chain Bioscience stock?
Light Chain Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Light Chain Bioscience's last funding round?
Light Chain Bioscience's most recent funding round was VC Round on May 11, 2016.
Who are the main investors in Light Chain Bioscience?
Key investors in Light Chain Bioscience include BZ Bank Aktiengesellschaft, Rosetta Capital.
Will Light Chain Bioscience IPO soon?
No public IPO plans have been announced for Light Chain Bioscience.
How can I track Light Chain Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Light Chain Bioscience's shares on secondary markets.